From: Antimicrobial use for selected diseases in cats in Switzerland
Parameter | Private practices | |
---|---|---|
Total number of cases | n = 216 | |
At least one of the symptoms listed in the guidelinesa | Yesb | 65 (30%) |
Unknown | 85 (39%) | |
Local wound treatment | Yesb | 156 (72%) |
Unknown | 12 (6%) | |
Drain placement | Yesb | 33 (15%) |
Antibiotic therapy | Yesb | 207 (96%) |
Antibiotic classes | Potentiated aminopenicillins | 132 (64%) |
Third generation cephalosporins | 52 (25%) | |
Aminopenicillins | 50 (24%) | |
First generation cephalosporins | 12 (6%) | |
Fluoroquinolones | 5 (3%) | |
Lincosamides | 4 (2%) | |
Penicillins | 1 (1%) | |
Combination or serial therapyc | Yesb | 48 (24%) |
Critically important antibioticc | Yesb | 57 (28%) |
Duration of therapy (days) | 7 (1 ̶24) | |
Justification scorec | 1 | 36 (17%) |
2 | 16 (7%) | |
3 | 14 (7%) | |
4 | 65 (30%) | |
Judgement not possible | 85 (39%) |